Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 Inventory

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 (HROWL) currently reports a inventory of $17M as of June 2026. That compares with $12M in the prior-year period — up 46.4% year over year. Use the charts on this page to explore Harrow- 8.625% NT REDEEM 30/04/2026 USD 25's inventory history and peer comparisons.

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25's inventory increased from $12M to $17M — a 46.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 reported $17M in inventory as of June 2026. That compares with $12M in the prior-year period — up 46.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $17M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Harrow- 8.625% NT REDEEM 30/04/2026 USD 25, and consider following HROWL for alerts when major investors trade the stock.

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 is classified in the Healthcare sector. On inventory, it currently shows $17M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HROWL with unrelated industries.